You just read:

Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China

News provided by

Ampio Pharmaceuticals, Inc.

Jul 16, 2012, 04:00 ET